Royalty Pharma plc [NASDAQ: RPRX] stock went on a downward path that fall over -1.36% on Thursday, amounting to a one-week price increase of more than 1.15%.
Over the last 12 months, RPRX stock dropped by -20.48%. The one-year Royalty Pharma plc stock forecast points to a potential upside of 31.9. The average equity rating for RPRX stock is currently 1.22, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $12.98 billion, with 446.69 million shares outstanding and 378.53 million shares in the current float. Compared to the average trading volume of 2.69M shares, RPRX stock reached a trading volume of 3003010 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Royalty Pharma plc [RPRX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RPRX shares is $42.66 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RPRX stock is a recommendation set at 1.22. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
UBS have made an estimate for Royalty Pharma plc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 14, 2022. While these analysts kept the previous recommendation, Scotiabank raised their target price to Sector Outperform. The new note on the price target was released on May 13, 2022, representing the official price target for Royalty Pharma plc stock. Previously, the target price had yet another raise to $56, while Goldman analysts kept a Buy rating on RPRX stock.
The Average True Range (ATR) for Royalty Pharma plc is set at 0.62, with the Price to Sales ratio for RPRX stock in the period of the last 12 months amounting to 5.51. The Price to Book ratio for the last quarter was 1.99, with the Price to Cash per share for the same quarter was set at 1.11. Price to Free Cash Flow for RPRX in the course of the last twelve months was 4.28 with Quick ratio for the last quarter at 7.90.
RPRX Stock Performance Analysis:
Royalty Pharma plc [RPRX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.15. With this latest performance, RPRX shares dropped by -4.28% in over the last four-week period, additionally plugging by 7.87% over the last 6 months – not to mention a drop of -20.48% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RPRX stock in for the last two-week period is set at 41.33, with the RSI for the last a single of trading hit 38.22, and the three-weeks RSI is set at 44.38 for Royalty Pharma plc [RPRX]. The present Moving Average for the last 50 days of trading for this stock 29.82, while it was recorded at 29.33 for the last single week of trading, and 28.92 for the last 200 days.
Insight into Royalty Pharma plc Fundamentals:
Royalty Pharma plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.90 and a Current Ratio set at 7.90.
RPRX Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RPRX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Royalty Pharma plc go to 3.20%.
Royalty Pharma plc [RPRX] Institutonal Ownership Details
The top three institutional holders of RPRX stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in RPRX stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in RPRX stock with ownership which is approximately 5.8386%.
